AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 8-KSEP 301 min read$VSEE

VSEE HEALTH, INC. (VSEE): Entry into a Material Definitive Agreement

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into Material Definitive Agreement. Additional Vanquish Convertible Note Financing As previously reported, on June 18, 2026, VSee Health, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Vanquish SPA”) with an instit

Original reporting
SEC EDGAR 8-K
Published Sep 30, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 8:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefCorporate actions
Primary signal
$VSEE
Bearish
high confidence
Mentioned
$VSEE
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$VSEEBearishLow
01

Why it matters

The financing adds $180k of debt with a 12% interest rate and a conversion price set at 65% of recent low prices, capping ownership at 4.99%. This modest raise is unlikely to move the stock significantly but introduces dilution risk.

02

Market read

A small‑cap financing event with limited market impact; primarily relevant to VSEE shareholders and potential convertible note investors.

03

What to watch

The note’s 12% interest and prepayment flexibility may affect cash flow if market conditions tighten.

Relevance 6/10Novelty 4/10Timing: filing date Sep 30 2026

Background

VSee Health, Inc. (VSEE) announced a material definitive agreement involving a convertible promissory note and the ability to raise additional funds.

Company-level read

Ticker impact

$VSEEBearishHigh confidence
Context

VSee Health filed an 8‑K reporting a new $180,550 convertible note issuance and the ability to raise up to $2.05 M in the next 12 months.

Expected impact

likely modest pressure as the market prices in the dilution risk and additional debt.

Evidence & confidence

Primary SEC filing discloses a fresh financing event; impact is limited by small amount and conversion caps.

Market effects

Sector

Minimal effect on the broader health‑tech sector; similar small‑cap financing rounds are common.

Regional

Limited to U.S. OTC market where VSEE trades.

Global

None

Counterpoint

What could challenge this read

If the conversion triggers at a low share price, dilution could be larger than anticipated, potentially hurting shareholders.

Key entities

  • company
    VSee Health, Inc.

    Issuer of the convertible note.

  • investor
    Vanquish

    Institutional investor receiving the note and holding conversion rights.

Read at source← All news

Related articles

JUL 31
$VSEEMedAI 8/10

VSee Health Signs LOI for Healthcare Platform Acquisition Target With Over $35 Million in Annualized Revenue

VSee Health (NASDAQ:VSEE) said it signed a non-binding letter of intent to acquire healthcare technology and operating assets for a vertically integrated healthcare commerce platform. VSee estimates the deal value at about $42 million, with target annualized revenue over $35 million and about $7 million EBITDA, unaudited. Closing depends on due diligence, definitive agreements, and approvals.

yahoo.com4 min
JUL 31
$VSEEMedAI 8/10

VSee Health to Acquire $35M Healthcare Commerce Platform

VSee Health, Inc. signed a non-binding LOI to acquire healthcare technology and operating assets valued at about $42 million. The target supports a clinic-based wellness commerce platform with an unaudited annual revenue run rate over $35 million and about $7 million in EBITDA. VSee says it would integrate ordering and payment workflows into its API virtual care platform, subject to due diligence and approvals.

hitconsultant.net4 min
JUL 30
$VSEEMed

VSee Health: VSee Enters into Letter of Intent to Acquire Vertically Integrated Healthcare Commerce Platform - Acquisition, Valued at $42Million, Would Add over $35Million in Annualized Revenue and Mo

VSee Health (NASDAQ:VSEE) said it entered a non-binding letter of intent to acquire certain healthcare technology and operating assets for a vertically integrated healthcare commerce platform. The target assets have an unaudited run rate above $35 million and EBITDA around $7 million. VSee expects a quick close without initial shareholder dilution, subject to due diligence and definitive agreements.

finanznachrichten.de4 min
JUN 5
$VSEEMed

VSEE HEALTH, INC. (VSEE): Completion of Acquisition or Disposition of Assets

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-99.1 3 vseeex99-1.htm EXHIBIT 99.1 Exhibit 99.1 VSEE HEALTH, INC. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS On May 31, 2026, VSee Health, Inc., a Delaware corporation (the “Company”) entered into a Stock Purchase Agreement (the “Purchase Agreement”) with

SEC EDGAR 8-K4 min